These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2870158)

  • 1. Use of lipid microspheres as a drug carrier for antitumour drugs.
    Mizushima Y; Shoji Y; Kato T; Fukushima M; Kurozumi S
    J Pharm Pharmacol; 1986 Feb; 38(2):132-4. PubMed ID: 2870158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of delta 7-prostaglandin A1 and delta 12-prostaglandin J2 in vitro and in vivo.
    Kato T; Fukushima M; Kurozumi S; Noyori R
    Cancer Res; 1986 Jul; 46(7):3538-42. PubMed ID: 3708585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandins in the treatment of cancer.
    Sasaki H; Fukushima M
    Anticancer Drugs; 1994 Apr; 5(2):131-8. PubMed ID: 8049495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmaceutical and pharmacological development of antitumor prostaglandins].
    Fukushima S; Kishimoto S; Takeuchi Y; Fukushima M; Suzuki M; Furuta K; Noyori R; Sasaki H; Kikuchi Y; Nakano M; Kurozumi S
    Nihon Rinsho; 1998 Mar; 56(3):663-9. PubMed ID: 9549353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumour activity of chlorimidazine on transplantable mouse tumour systems.
    Mircheva JJ; Pantev TP
    Chemotherapy; 1985; 31(6):472-5. PubMed ID: 4075859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumour activity of some cyclophosphazenes.
    Labarre JF; Faucher JP; Levy G; Sournies F; Cros S; François G
    Eur J Cancer (1965); 1979 May; 15(5):637-43. PubMed ID: 510331
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and antitumour activity of several new 4-aroyl-1-nitrosohydrazinecarboxamides.
    Gugova R; Topakbashian V; Lozeva S; Dimov S; Golovinsky E
    Drugs Exp Clin Res; 1997; 23(2):71-5. PubMed ID: 9309382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the activity of alpha/beta-triglycidylurazol (TGU; NSC-332488): a new antineoplastic compound.
    Atassi G; Dumont P; Vanhaelen C
    Eur J Cancer Clin Oncol; 1984 Sep; 20(9):1187-91. PubMed ID: 6541138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity, optimum administration method and pharmacokinetics of 13,14-dihydro-15-deoxy-deoxy-Delta7 -prostaglandin A1 methyl ester (TEI-9826) integrated in lipid microspheres (Lipo TEI-9826).
    Fukushima S; Takeuchi Y; Kishimoto S; Yamashita S; Uetsuki K; Shirakawa S; Suzuki M; Furuta K; Noyori R; Sasaki H; Kikuchi Y; Kita T; Yamori T; Sawada J; Kojima M; Hazato A; Kurozumi S; Fukushima M
    Anticancer Drugs; 2001 Mar; 12(3):221-34. PubMed ID: 11290870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and evaluation of o/w type emulsions containing antitumor prostaglandin.
    Fukushima S; Kishimoto S; Takeuchi Y; Fukushima M
    Adv Drug Deliv Rev; 2000 Dec; 45(1):65-75. PubMed ID: 11104898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new antitumour agent, batracylin, selected by a preclinical solid tumour model.
    Atassi G; Dumont P; Kabbe HJ; Yoder O
    Drugs Exp Clin Res; 1988; 14(9):571-4. PubMed ID: 3229319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human melanoma growth by prostaglandin A, D, and J analogues.
    Bregman MD; Funk C; Fukushima M
    Cancer Res; 1986 Jun; 46(6):2740-4. PubMed ID: 3698005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psychotropic drugs and new 1,5-benzodiazepine analogs as antitumor agents].
    Werner W; Wohlrabe K; Gutsche W; Jungstand W; Römer W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):637-42. PubMed ID: 6172326
    [No Abstract]   [Full Text] [Related]  

  • 14. Potent antitumour activity of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato)platinum(II) monohydrate (DWA2114R) against advanced L1210 leukaemia in mice.
    Akamatsu K; Endo K; Matsumoto T; Kamisango K; Morikawa K; Koizumi M; Koizumi K
    Br J Cancer; 1992 Nov; 66(5):827-32. PubMed ID: 1419625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a delta 5-homo-aza-steroidal ester in P388 and L1210 murine leukemias.
    Catsoulacos P; Camoutsis C; Wampler GL
    Oncology; 1982; 39(1):59-60. PubMed ID: 7058047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of platinum(II) choline complex on murine leukemias L1210 and P388.
    Ochocki J; Glinka R; Cieśliński M; Góra-Tybor J; Potemski P
    Pharmazie; 1997 Jul; 52(7):567-9. PubMed ID: 9266598
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of in vivo and in vitro drug sensitivities of Lewis lung carcinoma and P388 leukaemia to analogues of amsacrine.
    Baguley BC; Wilson WR
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):607-13. PubMed ID: 3653185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current NCI preclinical antitumor screening in vivo: results of tumor panel screening, 1976-1982, and future directions.
    Venditti JM; Wesley RA; Plowman J
    Adv Pharmacol Chemother; 1984; 20():1-20. PubMed ID: 6398966
    [No Abstract]   [Full Text] [Related]  

  • 19. Encapsulation of mitomycin C in albumin microspheres markedly alters pharmacokinetics, drug quinone reduction in tumour tissue and antitumour activity. Implications for the drugs' in vivo mechanism of action.
    Cummings J; Allan L; Smyth JF
    Biochem Pharmacol; 1994 Apr; 47(8):1345-56. PubMed ID: 8185643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged survival time of sarcoma 180-bearing mice treated with lipid microspheres-entrapped antitumor marine coral prostanoids.
    Honda A; Mori Y; Yamada Y; Nakaike S; Hayashi H; Otomo S
    Res Commun Chem Pathol Pharmacol; 1988 Sep; 61(3):413-6. PubMed ID: 3187200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.